Filling in the Gaps: Priming and the Ethics of Pharmaceutical Advertising

, A prime is a cue that makes associated concepts, behaviors, and goals more psychologically accessible to people, influencing their responses in subsequent related environments. I build a case that Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA) operates as a prime that causes...

Full description

Saved in:  
Bibliographic Details
Main Author: Biegler, Paul (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Johns Hopkins Univ. Press 2015
In: Kennedy Institute of Ethics journal
Year: 2015, Volume: 25, Issue: 2, Pages: 193-230
Online Access: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002 4500
001 182698657X
003 DE-627
005 20230428033645.0
007 cr uuu---uuuuu
008 221214s2015 xx |||||o 00| ||eng c
024 7 |a 10.1353/ken.2015.0008  |2 doi 
035 |a (DE-627)182698657X 
035 |a (DE-599)KXP182698657X 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Biegler, Paul  |e VerfasserIn  |4 aut 
245 1 0 |a Filling in the Gaps: Priming and the Ethics of Pharmaceutical Advertising 
264 1 |c 2015 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a , A prime is a cue that makes associated concepts, behaviors, and goals more psychologically accessible to people, influencing their responses in subsequent related environments. I build a case that Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA) operates as a prime that causes some viewers to prefer and pursue the advertised drug. Drawing on literature from social psychology I show that people subject to priming are mostly unaware of its influence and liable to misattribute the reasons for their primed actions. Misattribution typically includes heightened appraisals of the value of a primed goal. Consistent with this account, I argue that viewers primed by DTCA hold favorable, yet false beliefs about the safety and efficacy of the advertised drug. I further argue that, because those drug properties are material to viewers with the relevant illness, priming in DTCA can undermine the autonomy of their medicine choices. The threat to autonomy posed by priming in DTCA suggests it warrants attention from both regulators and the wider research community. It also adds further reason to be sceptical about the permissibility of this form of advertising. 
773 0 8 |i Enthalten in  |a Kennedy Institute of Ethics  |t Kennedy Institute of Ethics journal  |d Baltimore, Md. : Johns Hopkins Univ. Press, 1991  |g 25(2015), 2, Seite 193-230  |h Online-Ressource  |w (DE-627)320481840  |w (DE-600)2009887-X  |w (DE-576)266818668  |x 1086-3249  |7 nnns 
773 1 8 |g volume:25  |g year:2015  |g number:2  |g pages:193-230 
856 4 0 |u https://doi.org/10.1353/ken.2015.0008  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://muse.jhu.edu/pub/1/article/585293  |x Verlag  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4230897448 
LOK |0 003 DE-627 
LOK |0 004 182698657X 
LOK |0 005 20221214052548 
LOK |0 008 221214||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-12-05#ED94E59D34EE2515B62BEEB4550436812BF9423C 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
ORI |a SA-MARC-ixtheoa001.raw